Johnson & Johnson
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity.
Did you know?
Net income compounded at 10.0% annually over 6 years.
Current Price
$243.04
-0.44%GoodMoat Value
$210.09
13.6% overvaluedProfile
Valuation (TTM)
Market Cap$585.56B
P/E21.85
EV$595.03B
P/B7.18
Shares Out2.41B
P/Sales6.22
Revenue$94.19B
EV/EBITDA14.94
Johnson & Johnson (JNJ) Stock News
JNJ Stock News & Headlines
Latest stock news and headlines for Johnson & Johnson (JNJ). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $243.04. Market cap: $585.56B. Sector: Healthcare. Industry: Drug Manufacturers - General. This page aggregates the latest news articles relevant to JNJ from financial news sources, helping investors stay current on events that may impact Johnson & Johnson's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Johnson & Johnson (JNJ).